Skip to main content

Table 4 Correlation between ATF5 expression and clinicopathologic charateristics of 140 bladder cancer

From: Activating transcription factor 5 (ATF5) promotes tumorigenic capability and activates the Wnt/b-catenin pathway in bladder cancer

Characteristic

ATF5 protein level

Chi-square test

High (65)

Low(75)

P value

Age (> 60 versus ≤ 60 years)

36/29

42/33

0.942

Gender (M versus F)

46/19

60/15

0.238

Grade (low versus high)

42/23

61/14

0.034*

Stage (Ta-1 versus T2-4)

45/20

65/10

0.014*

Tumor Size (> 3 cm versus ≤ 3 cm)

21/44

14/61

0.079

Multiplicity (single versus multiple)

37/28

60/15

0.004**

Recurrence (Yes versus No)

24/41

14/61

0.022*

Progression (Yes versus No)

18/47

8/67

0.016*

  1. *P < 0.05, **P < 0.01